Leaps by Bayer
InvestorActiveLeaps by Bayer is Bayer's strategic impact investment unit accelerating transformative biotechnologies across the "10 Leaps" framework addressing fundamental challenges in health and agriculture. Since 2015, Leaps invested $1.5B+ in 50+ ventures developing disruptive innovations moving from treating symptoms to curing/preventing diseases and nourishing growing populations while restoring the planet. Portfolio companies including BlueRock Therapeutics (cell therapy) and CoverCress (winter oilseed crop) demonstrate Leaps' commitment to breakthrough life science innovation. Leaps combines Bayer's deep scientific capabilities with patient venture capital enabling sustained investment in transformational biotechnology breakthroughs.
Founder Intel
Sign in to read intel from founders who have worked with Leaps by Bayer.
What founders say about Leaps by Bayer
Be the first to share intel on Leaps by Bayer — it's free.
Get Started FreeRelated on The List
- Seattle Angel Conference — Investor · N America
- Ideaship — Investor · N America
- Radicle Growth — Investor · San Diego, CA, United States
- SNOCAP — Investor · USA
- ABC Impact — Investor · Singapore
Comparing options? Founders discuss fundraising in the forum, or browse the rest of The List.